The Association of Imaging Producers & Equipment Suppliers (AIPES) announced on 22 May that it had changed its name to Nuclear Medicine Europe (NM-EU). The association said the new name reflected its desire to represent industry's interests more effectively with regulators and improve its brand identity.
The decision to change the name was unanimously approved by the AIPES General Assembly in Brussels. It is effective immediately, but there will be a transition phase until July 2019 as the association's website, email, and other tools are changed.
Antonis Kalemis, PhD, is the first president of NM-EU.The first president of NM-EU is Antonis Kalemis, PhD, who had been the AIPES vice president and treasurer. Kalemis, who is also the business manager for molecular imaging at Siemens Healthineers, succeeds Michael Nader, who served as the final AIPES president.
"I am honored to take this position at such an important time for the industry," Kalemis said. "Nuclear Medicine Europe is the new name for an association with an illustrious history. With the advances in nuclear medicine, in the fields of diagnosis and therapy, this change will give us more global visibility and legitimacy and give our industry the place it deserves in Europe and beyond."
AIPES was founded in 1989, which was about when European authorities first began regulating nuclear medicine. It has established itself as a European industrial association working on promotion, awareness, and defense of nuclear medicine and molecular healthcare in Europe, and the organization is active in the field of imaging and therapy with molecular and radioactive tracers.
According to the AIPES website, "The main objective of our association in this field is to ensure the promotion of the economic and/or commercial interests of its members, in particular, by all means allowing to increase the awareness to the benefits of the products and services they offer."
The new name does not change the legal entity of the association, nor does it change its internal structure. The AIPES General Assembly, Executive Committee, and Working Groups will now be part of the NM-EU.
NM-EU Honorary President Guy Turquet de Beauregard said the name change was a more accurate reflection of the association's values, range of services, and stature in the medical environment. "Our sector is changing. Productivity has improved massively, and at the same time, we have lowered the [radiation] doses we use. Nuclear medicine is now cheaper, faster, and easier than ever before," he noted.
Out with the old, in with the new: How the logo was born. Image courtesy of NM-EU.With nuclear medicine becoming more and more integrated, the association had to position itself to represent every part of the industry, Turquet de Beauregard added. He pointed out that NM-EU's interests now covered every part of the line, including the processing plants used to transform material into pharmaceutical products, the heavily regulated transporters of the material, the technologically complex cameras used to perform the imaging, and the physicians and hospitals involved in performing the patient procedures.
![Examples of ultrasound findings and techniques. (A) Images in a 39-year-old male patient with a mass in the left thigh. The mass is heterogeneous on the B-mode US image (compared with the patient in D) and showed increased microvascularity (superb microvascular imaging [SMI]) and shear-wave elastography (SWE) values. Undifferentiated pleomorphic sarcoma was diagnosed at biopsy (with pleomorphic rhabdomyosarcoma in surgical specimen). (B) Images in an 18-year-old male patient with a mass in the left leg. The mass is hypoechoic on the B-mode image, with no other findings suggestive of malignancy. The lesion is in contact with the cortex of the tibia, which is slightly irregular. CT revealed a doubtful anteromedial tibial erosion. The microvascular study demonstrated high vascularization, suggestive of malignancy. Periosteal Ewing sarcoma was diagnosed with both histologic and immunohistochemical confirmation. (C) Images in a 69-year-old female patient with a lump growing on the outside of the left leg. Multiple SWE examinations were performed (please note the high values obtained in the measurements, whereas the color map highlights the stiffness relative to adjacent tissues). SMI showed areas of increased vascularization to target for sampling. Undifferentiated spindle cell sarcoma was diagnosed at biopsy, with residual leiomyosarcoma in the surgical specimen after neoadjuvant therapy. (D) Images in a 56-year-old female patient with a mass in the right thigh. The mass is heterogeneous at both B-mode ultrasound (similar to patient A) and MRI (coronal T2-weighted spectral attenuated inversion recovery [SPAIR]; T1-weighted pre-contrast and postcontrast imaging), which even shows uptake after the administration of paramagnetic contrast material, which is traditionally suggestive of malignancy. Low values at SMI and elastography are suggestive of benignity. Spindle cell lipoma was diagnosed at biopsy, with atypical spindle cell lipomatous tumor in the surgical specimen.](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/08/images-radiol250278fig2.APCFLSvX6p.jpg?auto=format%2Ccompress&fit=crop&h=100&q=70&w=100)
![Examples of ultrasound findings and techniques. (A) Images in a 39-year-old male patient with a mass in the left thigh. The mass is heterogeneous on the B-mode US image (compared with the patient in D) and showed increased microvascularity (superb microvascular imaging [SMI]) and shear-wave elastography (SWE) values. Undifferentiated pleomorphic sarcoma was diagnosed at biopsy (with pleomorphic rhabdomyosarcoma in surgical specimen). (B) Images in an 18-year-old male patient with a mass in the left leg. The mass is hypoechoic on the B-mode image, with no other findings suggestive of malignancy. The lesion is in contact with the cortex of the tibia, which is slightly irregular. CT revealed a doubtful anteromedial tibial erosion. The microvascular study demonstrated high vascularization, suggestive of malignancy. Periosteal Ewing sarcoma was diagnosed with both histologic and immunohistochemical confirmation. (C) Images in a 69-year-old female patient with a lump growing on the outside of the left leg. Multiple SWE examinations were performed (please note the high values obtained in the measurements, whereas the color map highlights the stiffness relative to adjacent tissues). SMI showed areas of increased vascularization to target for sampling. Undifferentiated spindle cell sarcoma was diagnosed at biopsy, with residual leiomyosarcoma in the surgical specimen after neoadjuvant therapy. (D) Images in a 56-year-old female patient with a mass in the right thigh. The mass is heterogeneous at both B-mode ultrasound (similar to patient A) and MRI (coronal T2-weighted spectral attenuated inversion recovery [SPAIR]; T1-weighted pre-contrast and postcontrast imaging), which even shows uptake after the administration of paramagnetic contrast material, which is traditionally suggestive of malignancy. Low values at SMI and elastography are suggestive of benignity. Spindle cell lipoma was diagnosed at biopsy, with atypical spindle cell lipomatous tumor in the surgical specimen.](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/08/images-radiol250278fig2.APCFLSvX6p.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
